Commentary · 21 Feb 2026
Conference abstractPublished 20 Oct 2014
Overcoming CML acquired resistance: Impact of cell differentiation and CD38 expression
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Acquired resistance through genetic mutations is a major obstacle in targeted cancer therapy, but the underlying mechanisms are poorly understood. Using chronic myeloid leukemia (CML) as a disease model, we studied mechanisms of CML acquired resistance to tyrosine kinase inhibitors. By examining genome-wide gene expression and Exome sequencing of CML cells before and after developing genetic resistance, we identified key changes in cellular differentiation status when CML cell acquired genetic resistance. Forced differentiation overcame CML acquired resistance by altering CD38 expression and cellular NAD metabolism, which led to inhibition of SIRT1 functions and error-prone DNA damage repair in CML cells and blocking mutation acquisition. Our study sheds novel insight of cancer acquired resistance and has clinical implication of using differentiation agents to overcome drug resistance to tyrosine kinase inhibitors.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Wen Yong Chen”
